Regulatory and Industry Insights & Lessons Learned

Closing Plenary Session & Fireside Chat - Regulatory and Industry Insights & Lessons Learned Wrapping up the conference it is important to hear from regulatory leaders to help frame the strategy for the era ahead. Lessons learned from organizations around the world will give individuals the most current insights for those difficult discussion back at your home base.

Facilitating Development of Advanced Therapies
Raj K. Puri, MD, Director, Division of Cellular & Gene Therapies
CBER, FDA
Industry and Regulatory Fireside Chat
Raj K. Puri, MD, PhD, Director, Division of Cellular & Gene Therapies
CBER, FDA
Patricia Hughes, PhD, Branch Chief, Division of Microbiology Assessment
CDER, FDA
John Balchunas, Workforce Director National Institute for
Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Lawrence Hill, CEO & VP Global Clinical Development
Gan & Lee USA
Maria Hoffman, Executive Director, Supply Chain Management
Merck
Closing Remarks & Adjourn
Joseph Famulare, Conference Chair, VP Global Compliance & External Collaboration
Genentech